The consequences of gestational coronavirus disease 2019(COVID-19) exposure on neonatal immunity are incompletely understood. While vertical transmission to the fetus is rare, maternal COVID-19 exposure can adversely impact the neonate by inducing placental pathology, or indirectly, via neonatal immune programming. To investigate the latter, Gilley et al. analyzed cytokine levels in cord blood mononuclear cells (CBMCs) obtained from neonates exposed to chorioamnionitis, gestational COVID-19, and unexposed controls. They observed that fetal exposure to maternal inflammation, by either SARS-CoV-2 infection or chorioamnionitis, exaggerated the pro-inflammatory cytokine response to neonatal bacterial pathogens in cultured CBMCs. While both chorioamnionitis and COVID-19 exposure exaggerated cytokine expression, there were differences in immune cell populations and cell-type specific responses. These interesting findings indicate that fetal exposure to inflammatory stimuli, even without fetal infection, results in changes in the neonatal immune cell phenotype and function leading to heightened immune activation. The results of this study differ from a trend towards a muted pro-inflammatory response seen in pediatric COVID-19, which is attributed to cause decreased disease severity. The mechanisms underlying neonatal immune programming, the timing and severity of maternal exposure in relationship to immune programming and long-term health consequences need to be explored in future studies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review
BMC Medicine Open Access 13 March 2024
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
References
Mirbeyk, M., Saghazadeh, A. & Rezaei, N. A systematic review of pregnant women with COVID-19 and their neonates. Arch. Gynecol. Obstet. 304, 5–38 (2021).
Gale, C. et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc. Health 5, 113–121 (2021).
Menden, H. L. et al. The SARS-CoV-2 E protein induces Toll-like receptor 2-mediated neonatal lung injury in a model of COVID-19 viremia that is rescued by the glucocorticoid ciclesonide. Am. J. Physiol. Lung Cell. Mol. Physiol. 324, L722–L736 (2023).
Lu-Culligan, A. et al. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med 2, 591–610.e10 (2021).
Rad, H. S. et al. The effects of COVID-19 on the placenta during pregnancy. Front. Immunol. 12, 743022 (2021).
Jain, V. G., Willis, K. A., Jobe, A. & Ambalavanan, N. Chorioamnionitis and neonatal outcomes. Pediatr. Res. 91, 289–296 (2022).
Jung, E. et al. The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications. Semin. Fetal Neonatal. Med. 25, 101146 (2020).
Gee, S. et al. The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate. Nat. Immunol. 22, 1490–1502 (2021).
Jain, A. et al. Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation. J. Pediatr. 160, 584–589.e1 (2012).
Nadeau-Vallée, M. et al. Antenatal suppression of IL-1 protects against inflammation-induced fetal injury and improves neonatal and developmental outcomes in mice. J. Immunol. 198, 2047–2062 (2017).
Sacco, K. et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 28, 1050–1062 (2022).
Abers, M. S. et al. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 6, e144455 (2021).
Gabriel, B. et al. Analysis of the TCR repertoire in HIV-exposed but uninfected infants. Sci. Rep. 9, 11954 (2019).
Babik, J. M., Cohan, D., Monto, A., Hartigan-O’Connor, D. J. & McCune, J. M. The human fetal immune response to hepatitis C virus exposure in utero. J. Infect. Dis. 203, 196–206 (2011).
Soraisham, A. S., Singhal, N., McMillan, D. D., Sauve, R. S. & Lee, S. K. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am. J. Obstet. Gynecol. 200, 372.e1–372.e6 (2009).
Ryan, L. et al. Neonates and COVID-19: state of the art: neonatal sepsis series. Pediatr. Res. 91, 432–439 (2022).
Funding
TB’s effort was partly supported by 5R01AI147778, VS’s effort was partly supported by (1R01 DK117296-05, 1R01 HL162937-01, VS).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: the abstract of this Comment was inadvertently included as the first paragraph in the original article.
Rights and permissions
About this article
Cite this article
Bradley, T., Tucker, M. & Sampath, V. Triggered - does maternal COVID-19 program an exaggerated immune response in neonates?. Pediatr Res 95, 1400–1401 (2024). https://doi.org/10.1038/s41390-023-03007-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-03007-0